← Evidence map

TrialBMJ open2022

What drives cancer clinical trial accrual? An empirical analysis of studies leading to FDA authorisation (2015-2020).

Kristina Jenei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

10 papers cite it

2022
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 36207035